Lipid raft- and protein kinase C-mediated synergism between glucocorticoid- and gonadotropin-releasing hormone signaling results in decreased cell proliferation

J Biol Chem. 2014 Apr 4;289(14):10235-51. doi: 10.1074/jbc.M113.544742. Epub 2014 Feb 19.

Abstract

Cross-talk between the glucocorticoid receptor (GR) and other receptors is emerging as a mechanism for fine-tuning cellular responses. We have previously shown that gonadotropin-releasing hormone (GnRH) ligand-independently activates the GR and synergistically modulates glucocorticoid-induced transcription of an endogenous gene in LβT2 pituitary gonadotrope precursor cells. Here, we investigated GR and GnRH receptor (GnRHR) cross-talk that involves co-localization with lipid rafts in LβT2 cells. We report that the GnRHR and a small population of the GR co-localize with the lipid raft protein flotillin-1 (Flot-1) at the plasma membrane and that the GR is present in a complex with Flot-1, independent of the presence of ligands. We found that the SGK-1 gene is up-regulated by Dex and GnRH alone, whereas a combination of both ligands resulted in a synergistic increase in SGK-1 mRNA levels. Using siRNA-mediated knockdown and antagonist strategies, we show that the gene-specific synergistic transcriptional response requires the GR, GnRHR, and Flot-1 as well as the protein kinase C pathway. Interestingly, although several GR cofactors are differentially recruited to the SGK-1 promoter in the presence of Dex and GnRH, GR levels remain unchanged compared with Dex treatment alone, suggesting that lipid raft association of the GR has a role in enhancing its transcriptional output in the nucleus. Finally, we show that Dex plus GnRH synergistically inhibit cell proliferation in a manner dependent on SGK-1 and Flot-1. Collectively the results support a mechanism whereby GR and GnRHR cross-talk within Flot-1-containing lipid rafts modulates cell proliferation via PKC activation and SGK-1 up-regulation.

Keywords: Cell Proliferation; Flotillin-1; Gene Regulation; Glucocorticoid Receptor; Glucocorticoids; GnRH Receptor; Lipid Rafts; Protein Kinase C (PKC); SGK-1; Synergism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • COS Cells
  • Cell Proliferation / drug effects*
  • Chlorocebus aethiops
  • Dexamethasone / agonists
  • Dexamethasone / pharmacology*
  • Drug Synergism
  • Gene Expression Regulation, Enzymologic / drug effects
  • Gene Expression Regulation, Enzymologic / genetics
  • Glucocorticoids / agonists
  • Glucocorticoids / pharmacology*
  • Gonadotropin-Releasing Hormone / agonists
  • Gonadotropin-Releasing Hormone / pharmacology*
  • Immediate-Early Proteins / genetics
  • Immediate-Early Proteins / metabolism
  • Membrane Microdomains / enzymology*
  • Membrane Microdomains / genetics
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism
  • Mice
  • Protein Kinase C / biosynthesis*
  • Protein Kinase C / genetics
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism
  • Receptors, Glucocorticoid / genetics
  • Receptors, Glucocorticoid / metabolism
  • Receptors, LHRH / genetics
  • Receptors, LHRH / metabolism
  • Up-Regulation / drug effects
  • Up-Regulation / genetics

Substances

  • Glucocorticoids
  • Immediate-Early Proteins
  • Membrane Proteins
  • Receptors, Glucocorticoid
  • Receptors, LHRH
  • flotillins
  • Gonadotropin-Releasing Hormone
  • Dexamethasone
  • Protein Serine-Threonine Kinases
  • serum-glucocorticoid regulated kinase
  • Protein Kinase C